Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study

Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study

Background: Patients with both atrial fibrillation (AF) and cardiovascular disease (CVD) may receive dual antithrombotic therapy (DAT) with both an anticoagulant and ≥1 antiplatelet agents. Avoiding prolonged duration of DAT and use of gastroprotective therapies reduces bleeding risk. Aim: To descri...

Full description

Bibliographic Details
Main Authors: Charis Xuan Xie, John Robson, Crystal Williams, Chris Carvalho, Stuart Rison, Zahra Raisi-Estabragh
Format: Article
Language:English
Published: Royal College of General Practitioners 2022-12-01
Series:BJGP Open
Subjects:
dual antithrombin therapy
anticoagulation
antiplatelets
atrial fibrillation
cardiovascular diseases
gastroprotection
bleeding risk
population health
Online Access:https://bjgpopen.org/content/6/4/BJGPO.2022.0048

Internet

https://bjgpopen.org/content/6/4/BJGPO.2022.0048

Similar Items